Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
metformin (glucophage) (1 trial)
tolvaptan (samsca) (1 trial)
celecoxib (celebrex) (1 trial)
beta-glucans (1 trial)
Kidney Diseases (Phase 3)
Polycystic Kidney, Autosomal Dominant (Phase 3)
Polycystic Kidney Diseases (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (4 total)